When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Bristol-Myers: Dividend Stock Low Valuation Boost From Celgene
Bristol-Myers Squibb Company
Bristol-Myers Squibb (BMY) is transforming itself into a more powerful biopharmaceutical company through the acquisition of Celgene (CELG). Although the stock gained about 21% since the merger was announced in January 2019, the valuation is still lower than many of the company's peers and the Major Drug Manufacturing industry as a whole.
It appears that the Celgene acquisition might not be fully reflected in the stock price. Investors could be skeptical of how large an impact the acquisition will be for Bristol-Myers. The skepticism could also be the result of not